Stock Chart

LNTH

$100.10 -0.14%
Score: 47.9 HOLD
LEAPs: SELL $105
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $105
Premium: $2.00
Expiry: Sep 17, 2027
Target: $104
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 1.11x (vs SPY: 0.8x | vs QQQ: 0.6x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 22, 2026
Falling Channel weak / forming — below our quality gate quality 59/100
A Falling Channel is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Historically breaks up 64% of the time; target hit in 60% of up-breaks (n=559)
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About LNTH - Lantheus Holdings, Inc

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes …

Key Statistics

Market Cap $7B
P/E Ratio 24.27

This LNTH stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track LNTH's price movements with trendlines, gamma walls, and key support/resistance levels.